Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Carbohydr Polym ; 340: 122328, 2024 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-38857995

RESUMO

This article presents a novel approach to treating prostate cancer using a nanocarrier composed of folic acid (FA), ß-cyclodextrin (ß-CD), and magnetic graphene oxide (MGO) as a theranostic agent. The carrier is designed to improve the solubility and bioavailability of curcumin, a potential therapeutic substance against prostate cancer. Folic acid receptors overexpressed on the surface of solid tumors, including prostate cancer, may facilitate targeted drug delivery to tumor cells while avoiding nonspecific effects on healthy tissues. The anticancer efficacy of Folic acid-curcumin@ß-CD-MGO in vitro was also examined on LNCaP (an androgen-dependent) and PC3 (an androgen-independent) prostate cancer cells. The relaxivity of nanoparticles in MRI images was also investigated as a diagnostic factor. The results showed a concentration-dependent inhibitory effect on cell proliferation, induction of oxidative damage, and apoptotic effects. Also, nanoparticle relaxometry shows that this agent can be used as a negative contrast agent in MRI images. Overall, this study represents a promising theranostic agent to improve the delivery and trace of curcumin and enhance its therapeutic potential in the treatment of prostate cancer.


Assuntos
Proliferação de Células , Curcumina , Ácido Fólico , Grafite , Neoplasias da Próstata , Nanomedicina Teranóstica , beta-Ciclodextrinas , Curcumina/química , Curcumina/farmacologia , Masculino , Grafite/química , Grafite/farmacologia , Humanos , Neoplasias da Próstata/tratamento farmacológico , Neoplasias da Próstata/diagnóstico por imagem , Neoplasias da Próstata/patologia , beta-Ciclodextrinas/química , Nanomedicina Teranóstica/métodos , Ácido Fólico/química , Ácido Fólico/farmacologia , Proliferação de Células/efeitos dos fármacos , Apoptose/efeitos dos fármacos , Linhagem Celular Tumoral , Antineoplásicos/farmacologia , Antineoplásicos/química , Portadores de Fármacos/química , Imageamento por Ressonância Magnética/métodos , Nanopartículas/química , Receptores de Folato com Âncoras de GPI/metabolismo , Liberação Controlada de Fármacos , Nanopartículas de Magnetita/química
2.
MAGMA ; 36(4): 565-575, 2023 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-36943581

RESUMO

PURPOSE: This study aims to investigate three different image processing methods on quantitative parameters of IVIM sequence, as well as apparent diffusion coefficients and simple perfusion fractions, for benign and malignant liver tumors. MATERIALS AND METHODS: IVIM images with 8 b-values (0-1000 s/mm2) and 1.5 T MRI scanner in 16 patients and 3 healthy people were obtained. Next, the regions of interest were selected for malignant, benign, and healthy liver regions (50, 56, and 12, respectively). Then, the bi-exponential equation of the IVIM technique was fitted with two segmented fitting methods as well as one full fitting method (three methods in total). Using the segmented fitting method, diffusion coefficient (D) is fixed with a mono-exponential equation with b-values that are greater than 200 s/mm2. The perfusion fraction (f) can then be calculated by extrapolating, as the first method, or fitting simultaneously with the pseudo-diffusion coefficient (D*) as the second method. In the full fitting method, as the third method, all IVIM parameters were obtained simultaneously. The mean values of parameters from different methods were compared in different grades of lesions. RESULTS: Our results indicate that the image processing method can change statistical comparisons between different groups for each parameter. The D value is the only quantity in this technique that does not depend on the fitting process and can be used as an indicator of comparison between studies (P < 0.05). The most effective method to distinguish liver lesions is the extrapolated f method (first method). This method created a significant difference (P < 0.05) between the perfusion parameters between benign and malignant lesions. CONCLUSION: Using extrapolated f is the most effective method of distinguishing liver lesions using IVIM parameters. The comparison between groups does not depend on the fitting method only for parameter D.


Assuntos
Neoplasias Encefálicas , Neoplasias Hepáticas , Humanos , Movimento (Física) , Processamento de Imagem Assistida por Computador/métodos , Imagem de Difusão por Ressonância Magnética/métodos , Abdome , Neoplasias Hepáticas/diagnóstico por imagem
3.
Eur J Pharm Sci ; 174: 106207, 2022 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-35577179

RESUMO

Theranostic agents use simultaneous for diagnostic and therapeutic procedures. In the present study, the effect of Gd-DOTA/doxorubicin-loaded perfluorohexane nanodroplets as a theranostic nanoparticle for control released drug delivery and ultrasound/MR imaging was investigated on B16F10 melanoma cancer cells. The intracellular uptake was performed by inductively coupled plasma optical emission spectrometry (ICP-OES) that indicated sonicated Gd-DOTA/DOX@PFH NDs uptake by cancer cells was approximately 1.5 times more than the non-sonicated nanodroplets after 12 h. In vitro and in vivo toxicity assays revealed that synthesized NDs are biocompatible and do not have organ toxicity. Ultrasound exposure significantly enhanced the release of doxorubicin from NDs (P-value< 0.05). Ultrasound echogenicity and T1-MRI relaxometry indicated that synthesized NDs have strong ultrasound signal intensity and high r1 relaxivity (6.34 mM-1 S-1). The concentration of DOX in mice vital organs for Gd-DOTA/DOX NDs was significantly lower than that of free DOX. Doxorubicin concentration after 150 min in the tumor region for the DOX-loaded Gd-NDs+US group reached 14.8 µg/g followed by sonication, which was 2.3 fold higher than that of the non-sonicated group. According to the obtained results, the synthesized nanodroplets, with excellent diagnostic (ultrasound/MRI) and therapeutic properties, could be promising theranostic agents in cancer imaging and drug delivery for chemotherapeutic application.


Assuntos
Melanoma , Medicina de Precisão , Animais , Linhagem Celular Tumoral , Preparações de Ação Retardada , Doxorrubicina/química , Doxorrubicina/uso terapêutico , Sistemas de Liberação de Medicamentos , Compostos Heterocíclicos , Imageamento por Ressonância Magnética , Melanoma/diagnóstico por imagem , Melanoma/tratamento farmacológico , Camundongos , Compostos Organometálicos , Nanomedicina Teranóstica/métodos , Ultrassonografia
4.
Ultrasonics ; 102: 106061, 2020 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-31948804

RESUMO

When a liquid is irradiated with high intensities of ultrasound irradiation, acoustic cavitation occurs. Since cavitation can be fatal to cells, it is utilized to destroy cancer tumors. Considering cavitation onset and bubbles collapse, the required ultrasonic intensity threshold can be significantly decreased in the presence of nanoparticles in a liquid. The effects of gold nanoparticles size on acoustic cavitation were investigated in this in vitro study. For this purpose, ultrasonic waves were used at intensities of 0.5, 1 and 2 W/cm2 and frequency of 1 MHz in the presence of F-Cys-GNPs with 15, 23 and 79 nm sizes and different concentrations (0.2, 1 and 5 µg/ml) in order to determine their effects on the viability of melanoma cells. This was performed at different incubation times 12, 24 and 36 h. The viability of melanoma cells decreased at higher concentrations and sizes of F-Cys-GNPs. The lowest viability of melanoma cells was seen in those containing 79, 23, and 15 nm F-Cys-GNPs. This finding could be explained from the concept that the nucleation sites on the surface of GNPs increase with an increase in size of GNPs, which results in an increase in the number of cavitation bubbles. Acoustic cavitation in the presence of gold nanoparticles can be used as a way for improving therapeutic effects on the tumors.


Assuntos
Ouro/farmacologia , Ablação por Ultrassom Focalizado de Alta Intensidade/métodos , Melanoma/terapia , Nanopartículas Metálicas , Estrutura Molecular , Tamanho da Partícula , Células Tumorais Cultivadas
5.
J Korean Med Sci ; 34(37): e243, 2019 Sep 30.
Artigo em Inglês | MEDLINE | ID: mdl-31559711

RESUMO

BACKGROUND: In this article, we estimated the combined effect of radiotherapy (RT) with ultrasound (US) wave and the ability of gold nanoparticles (GNPs) to improve their combined therapeutic effects. METHODS: At first, HeLa cells received the various treatment modalities: RT (6 MV; 0.5, 1, and 2 Gy), US irradiation (1 MHz; 0.5, 1, and 1.5 W/cm², 1 minute), and RT+US. Afterwards, the enhanced effect of US on RT was evaluated. Then, the effect of the synthesized GNPs at different concentrations (0.2, 1, and 5 µg/mL, 24 hours) was evaluated to assess the effect on HeLa cells combined with RT+US. Cell survival rates in the different treatment groups at 24, 48, and 72 hours post-treatment were evaluated using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide and trypan blue assays. RESULTS: Our results show US irradiation could enhance the effect of RT at the same radiation dose and could be utilized as a sensitizer agent for RT. Moreover, our findings indicate RT+US in combination with different nanoparticle concentrations could enhance the effect of RT+US so that they can improve the treatment results up to 9.93 times and act as sonodynamic-radiosensitivity. These results also indicate that the combination of RT with US along with GNPs has synergistic effects compared to RT or US alone. Cell survival results show that combining the low US waves (1.5 W/cm²), GNPs (5 µ/mL), and X-rays (2 Gy) increase the cytotoxicity on HeLa cell up to 95.8%. CONCLUSION: We concluded that GNPs could act as a good sensitizing agent in RT+US irradiation and could result in the synergistic effects.


Assuntos
Raios gama , Ouro/química , Nanopartículas Metálicas/química , Sobrevivência Celular/efeitos dos fármacos , Feminino , Células HeLa , Humanos , Ondas Ultrassônicas , Neoplasias do Colo do Útero/metabolismo , Neoplasias do Colo do Útero/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...